Targeted drugs Flashcards

(28 cards)

1
Q

What 4 drugs EGFR?

A
  1. Gefitinib (Iressa)
  2. Erlotinib (Tarceva)
  3. Cetuximab (Erbitux)
  4. Panitumumab (Vectibix)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 2 drugs target ERBB2 (HER2)?

A
  1. Trastuzumab (Herceptin)
  2. Lapatinib (Tykerb)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What 3 drugs target BCR-ABL?

A
  1. Imatinib (Gleevec)
  2. Dasatinib (Sprycel)
  3. Nilotinib (Tasigna)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What drug targets BRAF?

A
  1. Vemurafenib (Zelboraf)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What drug targets CTLA-4?

A
  1. Ipilimumab (Yervoy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does masitinib (Kinavet, masivet) target?

A

KIT
PDGFRa/b
Lyn
Fyn
FGFR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does Palladia target?

A

KIT (CD117)
VEGFR2
PDGFRb
Flt-3
CSFR1
RAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does sunitinib (Sutent) target?

A

VEGFR1/2/3
PDGFRa/b
RET
CSFR1
Flt-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does oclacitinib (Apoquel) target?

A

JAK 1 > JAK3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name 3 mTOR inhibitors.

A
  1. Rapamycin (Rapamune)
  2. Temsirolimus (Torisel)
  3. Everolimus (Zortress)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name a JAK2 inhibitor that improves QOL (not curative).

A

Ruxolitinib (Jakafi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name a RANKL antagonist?

A

osteoprotegerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the targets for sorafenib (Nexavar)?

A

VEGFR2-3
C-RAF
B-RAF
VEGF-C
FLT3
FGFR1
KIT
p38
PDGFR
RET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name two PD-1 inhibitors.

A
  1. Pembrolizumab (Keytruda)
  2. Nivolumab (Opdivo)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name a PD-L1 inhibitor.

A

Atezolizumab (Tecentriuq)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name a monoclonal antibody that targets CD52 in CLL.

A

Alemtuzumab (Lemtrada)

17
Q

What mAb targets VEGF?

A

Bevacizumab (Avastin)

18
Q

What mAb targets CD33 in AML? What toxin does it deliver?

A
  1. Gemtuzumab (Milotarg)
  2. ozogamicin
19
Q

What mAB’s target CD20? Include toxins for modified ab’s.

A
  1. Ibritumomab (Zevalin), toxin: yttrium-90
  2. Ofatumumab (Arzerra)
  3. Rituximab (Rituxan)
  4. Tositumomab (Bexxar), toxin: I-131
20
Q

Name a bispecific antibody that mediates regression of NH B cell LSA and is specific for CD19 and CD3?

A

Blinatumomab (Blincyto)

21
Q

Name a small molecule inhibitor that targets EML4-ALK translocation seen in a subset of patients with NSCLC.

A

Crizotinib (Xalkori)

22
Q

What small molecule inhibitor can be used to treat resistance from EGFR therapy for NSCLC?

A

Osimertinib (Tagrisso)

23
Q

Name a BTK inhibitor.

A

Ibrutinib (Imbruvica)

24
Q

Name two small molecule inhibitors of PI3K-gamma-delta.

A

tenalisib and duvelisib

25
Name 3 PARP inhibitors.
1. Olaparib (AstraZeneca) 2. Rucaparib (Rubraca) 3. Niraparib (Zejula)
26
Name 2 HDAC inhibitors.
Vorinostat (Zolinza) Romidepsin (Istodax)
27
Name 2 proteosome inhibitors.
1. Bortezomib (Velcade) 2. Carfilzomib (Kyrpolis)
28
Name 4 DMNT1 inhibitors.
1. VPA 2. 5-azacytidine 3. 5-aza-deoxycytidine 4. Zebularine